NAD+ (nicotinamide adenine dinucleotide) is a coenzyme essential to cellular energy metabolism and DNA repair, and its decline with age is one of the more consistently observed patterns in longevity research. The confusing part is that there are three very differently delivered products all claiming to address it, and they’re not interchangeable.
Three Different Delivery Strategies
| NAD+ | NMN | NR | |
|---|---|---|---|
| What it is | The coenzyme itself | A direct precursor, one enzymatic step away | A precursor two steps upstream |
| Typical delivery | Injectable (IV or subcutaneous) | Oral capsule | Oral capsule |
| Bioavailability consideration | Bypasses digestive breakdown entirely | Subject to gut absorption and conversion efficiency | Generally considered better absorbed orally than NMN, based on available research |
Why Direct NAD+ Injection Is Different
Injecting NAD+ directly bypasses the question of whether an oral precursor gets efficiently converted, since it delivers the finished coenzyme into circulation. The tradeoff is delivery complexity — it requires reconstitution and injection rather than a capsule — and injectable NAD+ protocols are also generally reported to carry a higher chance of mild infusion-related side effects like flushing or nausea, particularly with rapid administration.
Which One Should You Actually Research?
This isn’t a strict hierarchy. Oral NMN and NR are the lower-friction, lower-cost entry points for those wanting to explore the precursor pathway. Injectable NAD+ is of interest specifically to those wanting to skip the absorption-and-conversion question, at the cost of a more involved administration process. Some longevity-focused research protocols use both categories at different points rather than choosing one exclusively.
Sourcing
Injectable NAD+ is available through our research-vendor network below. NMN and NR are widely available as standard oral supplements through general supplement retailers.